Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $34.0K | $37.0K | $50.0K | $529.0K | $0 | $0 | $0 |
| Gross profit | −$34.0K | −$37.0K | −$50.0K | −$529.0K | −$525.0K | $0 | $0 |
| Gross margin | — | — | — | — | — | — | — |
| R&D | $13.1M | $15.9M | $28.2M | $37.7M | $56.1M | $43.8M | $48.3M |
| Operating income | −$15.5M | −$19.6M | −$39.8M | −$53.8M | −$83.1M | −$54.4M | −$63.0M |
| EBITDA | −$15.4M | −$19.5M | −$39.8M | −$53.8M | −$82.2M | $662.0K | −$63.0M |
| Net income | −$12.4M | −$19.5M | −$39.8M | −$50.1M | −$77.4M | $0 | $0 |
| Net margin | — | — | — | — | — | — | — |
| EPS (diluted) | -1.60 | -0.80 | -2.19 | -2.04 | -2.30 | 0.00 | -4.40 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $208M | $-2.71 | $-2.71–$-2.71 | 1 |
| 2027 | $425M | $-2.84 | $-2.84–$-2.84 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds RPHM.
No tracked institution reports a position in RPHM as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-10-07 | 1-for-10reverse |
No one on the platform has traded RPHM yet.
| $54M |
| — |
| QNCXQuince Therapeutics, Inc. | $0.92 | -2.43% | $5M | — |
| RNTXRein Therapeutics Inc. | $1.04 | +7.08% | $29M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Watch this before monday ⬇️🚨 The obesity / Weight loss theme/trend will change lives. This Trend Is Just Starting. $ARWR, $ROIV, $NVOS, $RPHM https://www.tiktok.com/@strategicstocksniper/video/7510661709116394798?is_from_webapp=1&sender_device=pc&web_id=7508604446427924010
View on StockTwits ↗$RPHM I apologize, but there is no existing article content provided in your message to modify or expand upon. The initial prompt states “Here is the article: No content returned.” This means there is no actual article text available to work with. https://beyondspx.com/article/i-apologize-but-there-is-no-existing-article-content-provided-in-your-message-to-modify-or-expand-upon-the-initial-prompt-states-here-is-the-article-no-content-returned-this-means-there-is-no-actual-article-text-available-to-work-with
View on StockTwits ↗$MNPR congrats if you got in! $ALP merger with $SER or SITC news due $OKUR key Breast cancer data due Q4 merged with $RPHM
View on StockTwits ↗$RPHM OKUR RPHM One of my bigger reverse merger bet. Let’s see some bio-gold blessing! 🍀🎉🍀
View on StockTwits ↗Reneo Pharmaceuticals ( $RPHM ) merges with OnKure Inc ( $OKUR ) - RPHM symbol change to OKUR effective today before market open, October 7th - Ownership : [RPHM shareholders to retain 25.1% of combined entity] [Prior OnKure shareholders to retain 53.6% of the combined entity] [Private placement investor to receive 21.3% of the newly combined company] - 1-for-10 reverse stock split alongside merger & offering. Shares outstanding for OKUR to be initially set at 74.2M (from prior RPHM count of 33.4M) More Information : https://www.globenewswire.com/news-release/2024/10/04/2958522/0/en/OnKure-Announces-Closing-of-Merger-with-Reneo-Pharmaceuticals-and-Concurrent-Private-Placement-of-65-Million.html
View on StockTwits ↗$RPHM https://finviz.com/quote.ashx?t=OKUR&ty=c&ta=1&p=d
View on StockTwits ↗$RPHM lets see 30+ today. a lot of shares locked up. might squeeze.
View on StockTwits ↗$RPHM I recently acquired 5000 shares at $1.70, with the merger & RS monday I know Ill only have 500 shares, what price do you think it will open at? 17? 19? Thanks in advance! $TECX
View on StockTwits ↗$RPHM OKUR RPHM RPHM ownership of merged company increased 2.57%. 🍀🎉🍀 10/4/24 PR at the closing of the merger there were approximately 13.3 million shares of common stock outstanding, with prior Reneo stockholders owning approximately 31.8% and prior OnKure, Inc. stockholders holding approximately 68.2% of the combined company's outstanding common stock before the concurrent financing. 5/13/24 PR Pre-merger Reneo stockholders are expected to own approximately 31% of the combined company, and pre-merger OnKure stockholders are expected to own approximately 69% of the combined company, upon the closing of the merger, exclusive of the PIPE financing. https://finance.yahoo.com/news/onkure-announces-closing-merger-reneo-205700248.html
View on StockTwits ↗$RPHM OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million. https://www.globenewswire.com/news-release/2024/10/04/2958522/0/en/OnKure-Announces-Closing-of-Merger-with-Reneo-Pharmaceuticals-and-Concurrent-Private-Placement-of-65-Million.html
View on StockTwits ↗$RPHM they have money into 2026, been swinging this since the 1.70s, on watch for next week , ticker change to OKUR on Monday.
View on StockTwits ↗$RPHM Welp, tmr on average, should be +19% (just looking at all recent comps). But this one is well better than average! long
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.